Featured Articles

Roche has moved a step closer to expanding the use of its immunotherapy Tecentriq® (atezolizumab) in early-stage colon cancer after the U.S. Food and Drug Administration (FDA) accepted…
Read More...

The United Kingdom has become the first country in Europe to approve Wegovy® pill (semaglutide tablets) for weight management, providing adults living with obesity or overweight a new…
Read More...

GSK has agreed to acquire clinical-stage biotechnology company Nuvalent for approximately $10.6 billion, strengthening its oncology portfolio with a trio of targeted lung cancer…
Read More...

Roche has moved a step closer to bringing a potential new treatment option to patients with early-stage breast cancer after the U.S. Food and Drug Administration (FDA) accepted the…
Read More...

Sanofi has received a significant regulatory boost after the U.S. Food and Drug Administration (FDA) granted priority review to the new drug application (NDA) for venglustat, an…
Read More...

Innovent Biologics and Pfizer have entered into a major global oncology collaboration aimed at accelerating the development of next-generation cancer therapies, with a deal potentially…
Read More...

Novo Nordisk presented new findings from its landmark POSEIDON real-world evidence study showing that cardiovascular inflammation remains highly prevalent among people living with…
Read More...

SK bioscience has signed an agreement with Colombia’s state-owned pharmaceutical company VECOL to support vaccine technology transfer and local manufacturing, marking a significant step…
Read More...

Eli Lilly and Company reported positive interim results from the Phase 1b Heart-2 clinical study of VERVE-102, an investigational gene-editing therapy designed to lower low-density…
Read More...

Bristol Myers Squibb and Anthropic have entered a strategic agreement to deploy Anthropic’s Claude artificial intelligence platform across Bristol Myers Squibb’s global operations,…
Read More...

Eli Lilly and Company reported positive topline results from its Phase 3 TRIUMPH-1 clinical trial, showing that investigational obesity treatment retatrutide delivered substantial and…
Read More...

Gilead Sciences has completed its previously announced acquisition of Germany-based biotechnology company Tubulis GmbH, strengthening its oncology pipeline with next-generation…
Read More...

QIAGEN announced a new collaboration with NVIDIA aimed at integrating accelerated computing and artificial intelligence into drug discovery workflows, a move the company says could help…
Read More...

GSK has announced an exclusive strategic collaboration with Sino Biopharmaceutical through its subsidiary Chia Tai Tianqing Pharmaceutical Group to accelerate the launch and…
Read More...

Swiss healthcare giant Roche has signed a definitive merger agreement to acquire U.S.-based artificial intelligence pathology company PathAI, strengthening its position in the rapidly…
Read More...

Novartis has begun construction on a new radioligand therapy (RLT) manufacturing facility in Denton, Texas, as part of the company’s expanding multibillion-dollar investment in U.S.…
Read More...

Eli Lilly and Company has announced an additional $4.5 billion investment in its Lebanon, Indiana manufacturing operations, strengthening the pharmaceutical giant’s long-term commitment…
Read More...

Waiv, formerly known as Owkin Dx, has entered into a collaboration with Daiichi Sankyo to support digital pathology biomarker discovery for an antibody-drug conjugate (ADC) development…
Read More...

MSD has announced the successful completion of its acquisition of Terns Pharmaceuticals, Inc., marking a significant move to strengthen its oncology pipeline and expand its portfolio of…
Read More...

UCB has announced a definitive agreement to acquire Candid Therapeutics in a deal valued at up to $2.2 billion, marking a significant expansion of its immunology pipeline and…
Read More...